BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• 

  Venture capitalists

  More Than One-Third of Biotechs Have Under a Year of Cash Left, EY Finds

  EY’s 2025 Biotech Beyond Borders report provides a sobering snapshot of the industry’s financial health, with more and more companies facing cash runways of less than one year. The analyst firm’s leaders urge a return to basics for biotech.

  June 18, 2025

   · 

  4 min read

   · 

  Ana Mulero
• 

  Regulatory

  FDA Chief’s New Voucher Program Could Ease Biotech Investors’ Anxiety

  Industry watchers responded mostly positively to the commissioner’s new voucher program, but worries remain over staffing cuts at the agency.

  June 18, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• 

  FDA

  Gilead Wins Historic Approval for Twice-Yearly HIV Drug

  Lenacapavir, to be marketed as Yeztugo, could “redefine the PReP market,” according to analysts.

  June 18, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• Press Releases

  Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)

  June 18, 2025

   · 

  5 min read
• Press Releases

  Expanding Innovations Receives FDA Clearance for N-GAGE™ Lumbar Plate System

  June 18, 2025

   · 

  2 min read
• Press Releases

  JCR Pharmaceuticals Announces Launch of Mucopolysaccharidosis (MPS) Type II Disease Awareness Film Featured in The Next Frontier Series

  June 18, 2025

   · 

  4 min read
• Press Releases

  Tulavi Therapeutics Appoints Raymond W. Cohen as Vice Chairman of its Board of Directors

  June 18, 2025

   · 

  2 min read
• Press Releases

  Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call

  June 18, 2025

   · 

  5 min read
• Press Releases

  DNA Read, Write and Edit Market are Powering a $26.46 Billion Genomics Revolution

  June 18, 2025

   · 

  1 min read
• Press Releases

  Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting

  June 18, 2025

   · 

  6 min read